March 01, 1989 article Optimal two-stage designs for phase II clinical trials Controlled Clinical Trials DOI: 10.1016/0197-2456(89)90015-9 OpenAlex Authors 0 Author list not loaded yet. Cited by 21 stored of 3,652 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access SCOPES-II: short course of preoperative radiotherapy in head and neck, trunk and extremity soft tissue sarcomas – study protocol for a second randomised phase II clinical trial 2026 BMJ Open article Medicine Sarcoma Diagnosis and Treatment Open access 0 citations Trametinib for NRAS-mutated tumors: Results from the Drug Rediscovery Protocol 2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways 0 citations Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC 2026 Nature Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 8 citations Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol 2025 International Journal of Cancer article Medicine PARP inhibition in cancer therapy Open access 3 citations Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses 2025 Clinical Cancer Research article Medicine Vascular Tumors and Angiosarcomas Open access 6 citations Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition 2025 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access 7 citations Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial 2024 Nature Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access 74 citations Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial 2024 Nature Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access 126 citations The Innate Immune Landscape of dMMR/MSI Cancers Predicts the Outcome of Nivolumab Treatment: Results from the Drug Rediscovery Protocol 2024 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 7 citations The evolution of precision oncology: The ongoing impact of the Drug Rediscovery Protocol (DRUP) 2024 Acta Oncologica article Medicine Lung Cancer Treatments and Mutations Open access 24 citations Efficacy of Pembrolizumab and Biomarker Analysis in Patients with WGS-Based Intermediate to High Tumor Mutational Load: Results from the Drug Rediscovery Protocol 2024 Clinical Cancer Research article Medicine Cancer Immunotherapy and Biomarkers Open access 4 citations Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4 /6 pathway alterations in the Dutch DRUP and Australian MoST trials 2023 International Journal of Cancer article Medicine Advanced Breast Cancer Therapies Open access 29 citations PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial 2023 Nature Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access 43 citations Data from Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment 2023 other Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access 0 citations New benchmarks to design clinical trials with advanced or metastatic liposarcoma or synovial sarcoma patients: An EORTC – Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis based on a literature review for soft-tissue sarcomas 2022 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access cited by 1 patent 14 citations Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial 2022 The Lancet Haematology article Medicine Hematopoietic Stem Cell Transplantation Open access 74 citations Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment 2022 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access 89 citations Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types 2021 Clinical Cancer Research article Medicine PARP inhibition in cancer therapy Open access 36 citations Neoadjuvant Cytoreductive Treatment With BRAF/MEK Inhibition of Prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR 2021 Annals of Surgery article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access 48 citations Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial 2021 Clinical Pharmacology & Therapeutics article Medicine Renal Transplantation Outcomes and Treatments Open access 44 citations 1–20 of 21 Page 1 / 2 Next → References 0